Urogen Pharma Competitors and Similar CompaniesClear all
ESSA Pharma's competitors and similar companies include LadRx and Fennec Pharma.
 ESSA Pharma ESSA Pharma is a pharmaceutical company focused on developing therapies for the treatment of prostate cancer. |  LadRx LadRx Corporation (formerly known as CytRx Corporation) is a biopharmaceutical company focused on discovering, developing and commercializing new therapeutics to treat patients with cancer. |  Fennec Pharma Fennec Pharmaceuticals is a biotechnology company focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients. | |
Founding Date | Founding Date 2009 | Founding Date 1985 | Founding Date 1996 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Vancouver, CA HQ Houston, US South San Francisco, US | Locations Los Angeles, US HQ | Locations US HQ |
Employees | Employees 35 | Employees 385% decrease | Employees 433% increase |
Valuation ($) | Valuation ($) 240 m | Valuation ($) 901.1 k | Valuation ($) 129.4 m |
Financial | |||
Net income | Net income ($28.5m) (FY, 2024) | Net income ($1.6m) (FY, 2024) | Net income ($9.7m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 74.1m | Total funding raised N/A | Total funding raised $ 2.2m |
For sources of this data, please see the company profile
View Company Profiles
LadRx
HQ
Los Angeles, US
Employees
3
LadRx Corporation (formerly known as CytRx Corporation) is a biopharmaceutical company focused on discovering, developing and commercializing new therapeutics to treat patients with cancer.
View companyFennec Pharma
HQ
US
Employees
4↑ 33% increase
Fennec Pharmaceuticals is a biotechnology company focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients.
View company